Global Roflumilast Production, Demand and Key Producers, 2022-2028
Novel COPD treatment drugs
This report studies the global Roflumilast production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Roflumilast, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Roflumilast that contribute to its increasing demand across many markets.
The global Roflumilast market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Roflumilast total production and demand, 2017-2028, (Box)
Global Roflumilast total production value, 2017-2028, (USD Million)
Global Roflumilast production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Box)
Global Roflumilast consumption by region & country, CAGR, 2017-2028 & (Box)
U.S. VS China: Roflumilast domestic production, consumption, key domestic manufacturers and share
Global Roflumilast production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Box)
Global Roflumilast production by Dosage Strength, production, value, CAGR, 2017-2028, (USD Million) & (Box)
Global Roflumilast production by Application production, value, CAGR, 2017-2028, (USD Million) & (Box)
This reports profiles key players in the global Roflumilast market based on the following parameters – headquarters, production locations, products portfolio, Roflumilast revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Roflumilast market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Box) and average price (US$/Box) by manufacturer, by Dosage Strength, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Roflumilast Market, By Region:
1. How big is the global Roflumilast market?
2. What is the demand of the global Roflumilast market?
3. What is the year over year growth of the global Roflumilast market?
4. What is the production and production value of the global Roflumilast market?
5. Who are the key producers in the global Roflumilast market?
6. What are the growth factors driving the market demand?
This report studies the global Roflumilast production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Roflumilast, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Roflumilast that contribute to its increasing demand across many markets.
The global Roflumilast market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Roflumilast total production and demand, 2017-2028, (Box)
Global Roflumilast total production value, 2017-2028, (USD Million)
Global Roflumilast production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Box)
Global Roflumilast consumption by region & country, CAGR, 2017-2028 & (Box)
U.S. VS China: Roflumilast domestic production, consumption, key domestic manufacturers and share
Global Roflumilast production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Box)
Global Roflumilast production by Dosage Strength, production, value, CAGR, 2017-2028, (USD Million) & (Box)
Global Roflumilast production by Application production, value, CAGR, 2017-2028, (USD Million) & (Box)
This reports profiles key players in the global Roflumilast market based on the following parameters – headquarters, production locations, products portfolio, Roflumilast revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Roflumilast market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Box) and average price (US$/Box) by manufacturer, by Dosage Strength, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Roflumilast Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- 250Mcg
- 500Mcg
- Hospital
- Clinic
- Other
- Alkem Laboratories
- Astra Zeneca
- Beltapharm Spa
- Breckenridge Pharma
- Hetero Drugs
- KMS Health Center
- Micro Labs
- MS Pharma
- MSN Laboratories
- Viatris
- Orchid Pharma
- Orifarm Group
- Precise Group
- Takeda Pharmaceutical
- Torrent Group
1. How big is the global Roflumilast market?
2. What is the demand of the global Roflumilast market?
3. What is the year over year growth of the global Roflumilast market?
4. What is the production and production value of the global Roflumilast market?
5. Who are the key producers in the global Roflumilast market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Roflumilast Introduction
1.2 World Roflumilast Supply & Forecast
1.2.1 World Roflumilast Production Value (2017 & 2021 & 2028)
1.2.2 World Roflumilast Production (2017-2028)
1.2.3 World Roflumilast Pricing Trends (2017-2028)
1.3 World Roflumilast Production by Region
1.3.1 World Roflumilast Production Value by Region (2017-2028)
1.3.2 World Roflumilast Production by Region (2017-2028)
1.3.3 World Roflumilast Average Price by Region (2017-2028)
1.3.4 North America Roflumilast Production (2017-2028)
1.3.5 Europe Roflumilast Production (2017-2028)
1.3.6 China Roflumilast Production (2017-2028)
1.3.7 Japan Roflumilast Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Roflumilast Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Roflumilast Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Roflumilast Demand (2017-2028)
2.2 World Roflumilast Consumption by Region
2.2.1 World Roflumilast Consumption by Region (2017-2022)
2.2.2 World Roflumilast Consumption Forecast by Region (2023-2028)
2.3 United States Roflumilast Consumption (2017-2028)
2.4 China Roflumilast Consumption (2017-2028)
2.5 Europe Roflumilast Consumption (2017-2028)
2.6 Japan Roflumilast Consumption (2017-2028)
2.7 South Korea Roflumilast Consumption (2017-2028)
2.8 ASEAN Roflumilast Consumption (2017-2028)
2.9 India Roflumilast Consumption (2017-2028)
3 WORLD ROFLUMILAST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Roflumilast Production Value by Manufacturer (2017-2022)
3.2 World Roflumilast Production by Manufacturer (2017-2022)
3.3 World Roflumilast Average Price by Manufacturer (2017-2022)
3.4 Roflumilast Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Roflumilast Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Roflumilast in 2021
3.5.3 Global Concentration Ratios (CR8) for Roflumilast in 2021
3.6 Roflumilast Market: Overall Company Footprint Analysis
3.6.1 Roflumilast Market: Region Footprint
3.6.2 Roflumilast Market: Company Product Type Footprint
3.6.3 Roflumilast Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Roflumilast Production Value Comparison
4.1.1 United States VS China: Roflumilast Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Roflumilast Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Roflumilast Production Comparison
4.2.1 United States VS China: Roflumilast Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Roflumilast Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Roflumilast Consumption Comparison
4.3.1 United States VS China: Roflumilast Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Roflumilast Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Roflumilast Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Roflumilast in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Roflumilast Production by Domestic Manufacturer, (2017-2022)
4.5 China Roflumilast Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Roflumilast in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Roflumilast Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Roflumilast Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Roflumilast in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Roflumilast Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY DOSAGE STRENGTH
5.1 World Roflumilast Market Size Overview by Dosage Strength: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Dosage Strength
5.2.1 250Mcg
5.2.2 500Mcg
5.3 Market Segment by Dosage Strength
5.3.1 World Roflumilast Production by Dosage Strength (2017-2028)
5.3.2 World Roflumilast Production Value by Dosage Strength (2017-2028)
5.3.3 World Roflumilast Average Price by Dosage Strength (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Roflumilast Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Roflumilast Production by Application (2017-2028)
6.3.2 World Roflumilast Production Value by Application (2017-2028)
6.3.3 World Roflumilast Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Alkem Laboratories
7.1.1 Alkem Laboratories Details
7.1.2 Alkem Laboratories Major Business
7.1.3 Alkem Laboratories Roflumilast Product and Services
7.1.4 Alkem Laboratories Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Alkem Laboratories Recent Developments/Updates
7.1.6 Alkem Laboratories Competitive Strengths & Weaknesses
7.2 Astra Zeneca
7.2.1 Astra Zeneca Details
7.2.2 Astra Zeneca Major Business
7.2.3 Astra Zeneca Roflumilast Product and Services
7.2.4 Astra Zeneca Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Astra Zeneca Recent Developments/Updates
7.2.6 Astra Zeneca Competitive Strengths & Weaknesses
7.3 Beltapharm Spa
7.3.1 Beltapharm Spa Details
7.3.2 Beltapharm Spa Major Business
7.3.3 Beltapharm Spa Roflumilast Product and Services
7.3.4 Beltapharm Spa Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Beltapharm Spa Recent Developments/Updates
7.3.6 Beltapharm Spa Competitive Strengths & Weaknesses
7.4 Breckenridge Pharma
7.4.1 Breckenridge Pharma Details
7.4.2 Breckenridge Pharma Major Business
7.4.3 Breckenridge Pharma Roflumilast Product and Services
7.4.4 Breckenridge Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Breckenridge Pharma Recent Developments/Updates
7.4.6 Breckenridge Pharma Competitive Strengths & Weaknesses
7.5 Hetero Drugs
7.5.1 Hetero Drugs Details
7.5.2 Hetero Drugs Major Business
7.5.3 Hetero Drugs Roflumilast Product and Services
7.5.4 Hetero Drugs Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Hetero Drugs Recent Developments/Updates
7.5.6 Hetero Drugs Competitive Strengths & Weaknesses
7.6 KMS Health Center
7.6.1 KMS Health Center Details
7.6.2 KMS Health Center Major Business
7.6.3 KMS Health Center Roflumilast Product and Services
7.6.4 KMS Health Center Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 KMS Health Center Recent Developments/Updates
7.6.6 KMS Health Center Competitive Strengths & Weaknesses
7.7 Micro Labs
7.7.1 Micro Labs Details
7.7.2 Micro Labs Major Business
7.7.3 Micro Labs Roflumilast Product and Services
7.7.4 Micro Labs Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Micro Labs Recent Developments/Updates
7.7.6 Micro Labs Competitive Strengths & Weaknesses
7.8 MS Pharma
7.8.1 MS Pharma Details
7.8.2 MS Pharma Major Business
7.8.3 MS Pharma Roflumilast Product and Services
7.8.4 MS Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 MS Pharma Recent Developments/Updates
7.8.6 MS Pharma Competitive Strengths & Weaknesses
7.9 MSN Laboratories
7.9.1 MSN Laboratories Details
7.9.2 MSN Laboratories Major Business
7.9.3 MSN Laboratories Roflumilast Product and Services
7.9.4 MSN Laboratories Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 MSN Laboratories Recent Developments/Updates
7.9.6 MSN Laboratories Competitive Strengths & Weaknesses
7.10 Viatris
7.10.1 Viatris Details
7.10.2 Viatris Major Business
7.10.3 Viatris Roflumilast Product and Services
7.10.4 Viatris Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Viatris Recent Developments/Updates
7.10.6 Viatris Competitive Strengths & Weaknesses
7.11 Orchid Pharma
7.11.1 Orchid Pharma Details
7.11.2 Orchid Pharma Major Business
7.11.3 Orchid Pharma Roflumilast Product and Services
7.11.4 Orchid Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Orchid Pharma Recent Developments/Updates
7.11.6 Orchid Pharma Competitive Strengths & Weaknesses
7.12 Orifarm Group
7.12.1 Orifarm Group Details
7.12.2 Orifarm Group Major Business
7.12.3 Orifarm Group Roflumilast Product and Services
7.12.4 Orifarm Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Orifarm Group Recent Developments/Updates
7.12.6 Orifarm Group Competitive Strengths & Weaknesses
7.13 Precise Group
7.13.1 Precise Group Details
7.13.2 Precise Group Major Business
7.13.3 Precise Group Roflumilast Product and Services
7.13.4 Precise Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Precise Group Recent Developments/Updates
7.13.6 Precise Group Competitive Strengths & Weaknesses
7.14 Takeda Pharmaceutical
7.14.1 Takeda Pharmaceutical Details
7.14.2 Takeda Pharmaceutical Major Business
7.14.3 Takeda Pharmaceutical Roflumilast Product and Services
7.14.4 Takeda Pharmaceutical Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Takeda Pharmaceutical Recent Developments/Updates
7.14.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.15 Torrent Group
7.15.1 Torrent Group Details
7.15.2 Torrent Group Major Business
7.15.3 Torrent Group Roflumilast Product and Services
7.15.4 Torrent Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Torrent Group Recent Developments/Updates
7.15.6 Torrent Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Roflumilast and Key Manufacturers
8.2 Roflumilast Manufacturing Costs
8.3 Roflumilast Production Process
8.4 Roflumilast Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Roflumilast Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Roflumilast Typical Distributors
9.3 Roflumilast Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Roflumilast Introduction
1.2 World Roflumilast Supply & Forecast
1.2.1 World Roflumilast Production Value (2017 & 2021 & 2028)
1.2.2 World Roflumilast Production (2017-2028)
1.2.3 World Roflumilast Pricing Trends (2017-2028)
1.3 World Roflumilast Production by Region
1.3.1 World Roflumilast Production Value by Region (2017-2028)
1.3.2 World Roflumilast Production by Region (2017-2028)
1.3.3 World Roflumilast Average Price by Region (2017-2028)
1.3.4 North America Roflumilast Production (2017-2028)
1.3.5 Europe Roflumilast Production (2017-2028)
1.3.6 China Roflumilast Production (2017-2028)
1.3.7 Japan Roflumilast Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Roflumilast Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Roflumilast Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Roflumilast Demand (2017-2028)
2.2 World Roflumilast Consumption by Region
2.2.1 World Roflumilast Consumption by Region (2017-2022)
2.2.2 World Roflumilast Consumption Forecast by Region (2023-2028)
2.3 United States Roflumilast Consumption (2017-2028)
2.4 China Roflumilast Consumption (2017-2028)
2.5 Europe Roflumilast Consumption (2017-2028)
2.6 Japan Roflumilast Consumption (2017-2028)
2.7 South Korea Roflumilast Consumption (2017-2028)
2.8 ASEAN Roflumilast Consumption (2017-2028)
2.9 India Roflumilast Consumption (2017-2028)
3 WORLD ROFLUMILAST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Roflumilast Production Value by Manufacturer (2017-2022)
3.2 World Roflumilast Production by Manufacturer (2017-2022)
3.3 World Roflumilast Average Price by Manufacturer (2017-2022)
3.4 Roflumilast Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Roflumilast Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Roflumilast in 2021
3.5.3 Global Concentration Ratios (CR8) for Roflumilast in 2021
3.6 Roflumilast Market: Overall Company Footprint Analysis
3.6.1 Roflumilast Market: Region Footprint
3.6.2 Roflumilast Market: Company Product Type Footprint
3.6.3 Roflumilast Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Roflumilast Production Value Comparison
4.1.1 United States VS China: Roflumilast Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Roflumilast Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Roflumilast Production Comparison
4.2.1 United States VS China: Roflumilast Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Roflumilast Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Roflumilast Consumption Comparison
4.3.1 United States VS China: Roflumilast Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Roflumilast Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Roflumilast Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Roflumilast in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Roflumilast Production by Domestic Manufacturer, (2017-2022)
4.5 China Roflumilast Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Roflumilast in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Roflumilast Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Roflumilast Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Roflumilast in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Roflumilast Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Roflumilast Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY DOSAGE STRENGTH
5.1 World Roflumilast Market Size Overview by Dosage Strength: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Dosage Strength
5.2.1 250Mcg
5.2.2 500Mcg
5.3 Market Segment by Dosage Strength
5.3.1 World Roflumilast Production by Dosage Strength (2017-2028)
5.3.2 World Roflumilast Production Value by Dosage Strength (2017-2028)
5.3.3 World Roflumilast Average Price by Dosage Strength (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Roflumilast Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Roflumilast Production by Application (2017-2028)
6.3.2 World Roflumilast Production Value by Application (2017-2028)
6.3.3 World Roflumilast Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Alkem Laboratories
7.1.1 Alkem Laboratories Details
7.1.2 Alkem Laboratories Major Business
7.1.3 Alkem Laboratories Roflumilast Product and Services
7.1.4 Alkem Laboratories Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Alkem Laboratories Recent Developments/Updates
7.1.6 Alkem Laboratories Competitive Strengths & Weaknesses
7.2 Astra Zeneca
7.2.1 Astra Zeneca Details
7.2.2 Astra Zeneca Major Business
7.2.3 Astra Zeneca Roflumilast Product and Services
7.2.4 Astra Zeneca Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Astra Zeneca Recent Developments/Updates
7.2.6 Astra Zeneca Competitive Strengths & Weaknesses
7.3 Beltapharm Spa
7.3.1 Beltapharm Spa Details
7.3.2 Beltapharm Spa Major Business
7.3.3 Beltapharm Spa Roflumilast Product and Services
7.3.4 Beltapharm Spa Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Beltapharm Spa Recent Developments/Updates
7.3.6 Beltapharm Spa Competitive Strengths & Weaknesses
7.4 Breckenridge Pharma
7.4.1 Breckenridge Pharma Details
7.4.2 Breckenridge Pharma Major Business
7.4.3 Breckenridge Pharma Roflumilast Product and Services
7.4.4 Breckenridge Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Breckenridge Pharma Recent Developments/Updates
7.4.6 Breckenridge Pharma Competitive Strengths & Weaknesses
7.5 Hetero Drugs
7.5.1 Hetero Drugs Details
7.5.2 Hetero Drugs Major Business
7.5.3 Hetero Drugs Roflumilast Product and Services
7.5.4 Hetero Drugs Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Hetero Drugs Recent Developments/Updates
7.5.6 Hetero Drugs Competitive Strengths & Weaknesses
7.6 KMS Health Center
7.6.1 KMS Health Center Details
7.6.2 KMS Health Center Major Business
7.6.3 KMS Health Center Roflumilast Product and Services
7.6.4 KMS Health Center Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 KMS Health Center Recent Developments/Updates
7.6.6 KMS Health Center Competitive Strengths & Weaknesses
7.7 Micro Labs
7.7.1 Micro Labs Details
7.7.2 Micro Labs Major Business
7.7.3 Micro Labs Roflumilast Product and Services
7.7.4 Micro Labs Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Micro Labs Recent Developments/Updates
7.7.6 Micro Labs Competitive Strengths & Weaknesses
7.8 MS Pharma
7.8.1 MS Pharma Details
7.8.2 MS Pharma Major Business
7.8.3 MS Pharma Roflumilast Product and Services
7.8.4 MS Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 MS Pharma Recent Developments/Updates
7.8.6 MS Pharma Competitive Strengths & Weaknesses
7.9 MSN Laboratories
7.9.1 MSN Laboratories Details
7.9.2 MSN Laboratories Major Business
7.9.3 MSN Laboratories Roflumilast Product and Services
7.9.4 MSN Laboratories Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 MSN Laboratories Recent Developments/Updates
7.9.6 MSN Laboratories Competitive Strengths & Weaknesses
7.10 Viatris
7.10.1 Viatris Details
7.10.2 Viatris Major Business
7.10.3 Viatris Roflumilast Product and Services
7.10.4 Viatris Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Viatris Recent Developments/Updates
7.10.6 Viatris Competitive Strengths & Weaknesses
7.11 Orchid Pharma
7.11.1 Orchid Pharma Details
7.11.2 Orchid Pharma Major Business
7.11.3 Orchid Pharma Roflumilast Product and Services
7.11.4 Orchid Pharma Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Orchid Pharma Recent Developments/Updates
7.11.6 Orchid Pharma Competitive Strengths & Weaknesses
7.12 Orifarm Group
7.12.1 Orifarm Group Details
7.12.2 Orifarm Group Major Business
7.12.3 Orifarm Group Roflumilast Product and Services
7.12.4 Orifarm Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Orifarm Group Recent Developments/Updates
7.12.6 Orifarm Group Competitive Strengths & Weaknesses
7.13 Precise Group
7.13.1 Precise Group Details
7.13.2 Precise Group Major Business
7.13.3 Precise Group Roflumilast Product and Services
7.13.4 Precise Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Precise Group Recent Developments/Updates
7.13.6 Precise Group Competitive Strengths & Weaknesses
7.14 Takeda Pharmaceutical
7.14.1 Takeda Pharmaceutical Details
7.14.2 Takeda Pharmaceutical Major Business
7.14.3 Takeda Pharmaceutical Roflumilast Product and Services
7.14.4 Takeda Pharmaceutical Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Takeda Pharmaceutical Recent Developments/Updates
7.14.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.15 Torrent Group
7.15.1 Torrent Group Details
7.15.2 Torrent Group Major Business
7.15.3 Torrent Group Roflumilast Product and Services
7.15.4 Torrent Group Roflumilast Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Torrent Group Recent Developments/Updates
7.15.6 Torrent Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Roflumilast and Key Manufacturers
8.2 Roflumilast Manufacturing Costs
8.3 Roflumilast Production Process
8.4 Roflumilast Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Roflumilast Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Roflumilast Typical Distributors
9.3 Roflumilast Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Roflumilast Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Roflumilast Production Value by Region (2017-2022) & (USD Million)
Table 3. World Roflumilast Production Value by Region (2023-2028) & (USD Million)
Table 4. World Roflumilast Production Value Market Share by Region (2017-2022)
Table 5. World Roflumilast Production Value Market Share by Region (2023-2028)
Table 6. World Roflumilast Production by Region (2017-2022) & (Box)
Table 7. World Roflumilast Production by Region (2023-2028) & (Box)
Table 8. World Roflumilast Production Market Share by Region (2017-2022)
Table 9. World Roflumilast Production Market Share by Region (2023-2028)
Table 10. World Roflumilast Average Price by Region (2017-2022) & (US$/Box)
Table 11. World Roflumilast Average Price by Region (2023-2028) & (US$/Box)
Table 12. Roflumilast Major Market Trends
Table 13. World Roflumilast Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Box)
Table 14. World Roflumilast Consumption by Region (2017-2022) & (Box)
Table 15. World Roflumilast Consumption Forecast by Region (2023-2028) & (Box)
Table 16. World Roflumilast Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Roflumilast Producers in 2021
Table 18. World Roflumilast Production by Manufacturer (2017-2022) & (Box)
Table 19. Production Market Share of Key Roflumilast Producers in 2021
Table 20. World Roflumilast Average Price by Manufacturer (2017-2022) & (US$/Box)
Table 21. Global Roflumilast Company Evaluation Quadrant
Table 22. World Roflumilast Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Roflumilast Production Site of Key Manufacturer
Table 24. Roflumilast Market: Company Product Type Footprint
Table 25. Roflumilast Market: Company Product Application Footprint
Table 26. Roflumilast Competitive Factors
Table 27. Roflumilast New Entrant and Capacity Expansion Plans
Table 28. Roflumilast Mergers & Acquisitions Activity
Table 29. United States VS China Roflumilast Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Roflumilast Production Comparison, (2017 & 2021 & 2028) & (Box)
Table 31. United States VS China Roflumilast Consumption Comparison, (2017 & 2021 & 2028) & (Box)
Table 32. Major Manufacturer of Roflumilast in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 36. United States Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Roflumilast in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 41. China Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Roflumilast in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 46. Rest of World Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Roflumilast Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Table 48. World Roflumilast Production by Dosage Strength (2017-2022) & (Box)
Table 49. World Roflumilast Production by Dosage Strength (2023-2028) & (Box)
Table 50. World Roflumilast Production Value by Dosage Strength (2017-2022) & (USD Million)
Table 51. World Roflumilast Production Value by Dosage Strength (2023-2028) & (USD Million)
Table 52. World Roflumilast Average Price by Dosage Strength (2017-2022) & (US$/Box)
Table 53. World Roflumilast Average Price by Dosage Strength (2023-2028) & (US$/Box)
Table 54. World Roflumilast Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Roflumilast Production by Application (2017-2022) & (Box)
Table 56. World Roflumilast Production by Application (2023-2028) & (Box)
Table 57. World Roflumilast Production Value by Application (2017-2022) & (USD Million)
Table 58. World Roflumilast Production Value by Application (2023-2028) & (USD Million)
Table 59. World Roflumilast Average Price by Application (2017-2022) & (US$/Box)
Table 60. World Roflumilast Average Price by Application (2023-2028) & (US$/Box)
Table 61. Alkem Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Alkem Laboratories Major Business
Table 63. Alkem Laboratories Roflumilast Product and Services
Table 64. Alkem Laboratories Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Alkem Laboratories Recent Developments/Updates
Table 66. Alkem Laboratories Competitive Strengths & Weaknesses
Table 67. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 68. Astra Zeneca Major Business
Table 69. Astra Zeneca Roflumilast Product and Services
Table 70. Astra Zeneca Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Astra Zeneca Recent Developments/Updates
Table 72. Astra Zeneca Competitive Strengths & Weaknesses
Table 73. Beltapharm Spa Basic Information, Manufacturing Base and Competitors
Table 74. Beltapharm Spa Major Business
Table 75. Beltapharm Spa Roflumilast Product and Services
Table 76. Beltapharm Spa Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Beltapharm Spa Recent Developments/Updates
Table 78. Beltapharm Spa Competitive Strengths & Weaknesses
Table 79. Breckenridge Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Breckenridge Pharma Major Business
Table 81. Breckenridge Pharma Roflumilast Product and Services
Table 82. Breckenridge Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Breckenridge Pharma Recent Developments/Updates
Table 84. Breckenridge Pharma Competitive Strengths & Weaknesses
Table 85. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 86. Hetero Drugs Major Business
Table 87. Hetero Drugs Roflumilast Product and Services
Table 88. Hetero Drugs Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Hetero Drugs Recent Developments/Updates
Table 90. Hetero Drugs Competitive Strengths & Weaknesses
Table 91. KMS Health Center Basic Information, Manufacturing Base and Competitors
Table 92. KMS Health Center Major Business
Table 93. KMS Health Center Roflumilast Product and Services
Table 94. KMS Health Center Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. KMS Health Center Recent Developments/Updates
Table 96. KMS Health Center Competitive Strengths & Weaknesses
Table 97. Micro Labs Basic Information, Manufacturing Base and Competitors
Table 98. Micro Labs Major Business
Table 99. Micro Labs Roflumilast Product and Services
Table 100. Micro Labs Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Micro Labs Recent Developments/Updates
Table 102. Micro Labs Competitive Strengths & Weaknesses
Table 103. MS Pharma Basic Information, Manufacturing Base and Competitors
Table 104. MS Pharma Major Business
Table 105. MS Pharma Roflumilast Product and Services
Table 106. MS Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. MS Pharma Recent Developments/Updates
Table 108. MS Pharma Competitive Strengths & Weaknesses
Table 109. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 110. MSN Laboratories Major Business
Table 111. MSN Laboratories Roflumilast Product and Services
Table 112. MSN Laboratories Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. MSN Laboratories Recent Developments/Updates
Table 114. MSN Laboratories Competitive Strengths & Weaknesses
Table 115. Viatris Basic Information, Manufacturing Base and Competitors
Table 116. Viatris Major Business
Table 117. Viatris Roflumilast Product and Services
Table 118. Viatris Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Viatris Recent Developments/Updates
Table 120. Viatris Competitive Strengths & Weaknesses
Table 121. Orchid Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Orchid Pharma Major Business
Table 123. Orchid Pharma Roflumilast Product and Services
Table 124. Orchid Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Orchid Pharma Recent Developments/Updates
Table 126. Orchid Pharma Competitive Strengths & Weaknesses
Table 127. Orifarm Group Basic Information, Manufacturing Base and Competitors
Table 128. Orifarm Group Major Business
Table 129. Orifarm Group Roflumilast Product and Services
Table 130. Orifarm Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Orifarm Group Recent Developments/Updates
Table 132. Orifarm Group Competitive Strengths & Weaknesses
Table 133. Precise Group Basic Information, Manufacturing Base and Competitors
Table 134. Precise Group Major Business
Table 135. Precise Group Roflumilast Product and Services
Table 136. Precise Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Precise Group Recent Developments/Updates
Table 138. Precise Group Competitive Strengths & Weaknesses
Table 139. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Takeda Pharmaceutical Major Business
Table 141. Takeda Pharmaceutical Roflumilast Product and Services
Table 142. Takeda Pharmaceutical Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Takeda Pharmaceutical Recent Developments/Updates
Table 144. Torrent Group Basic Information, Manufacturing Base and Competitors
Table 145. Torrent Group Major Business
Table 146. Torrent Group Roflumilast Product and Services
Table 147. Torrent Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Roflumilast Raw Material
Table 149. Key Manufacturers of Roflumilast Raw Materials
Table 150. Roflumilast Typical Distributors
Table 151. Roflumilast Typical Customers
Table 1. World Roflumilast Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Roflumilast Production Value by Region (2017-2022) & (USD Million)
Table 3. World Roflumilast Production Value by Region (2023-2028) & (USD Million)
Table 4. World Roflumilast Production Value Market Share by Region (2017-2022)
Table 5. World Roflumilast Production Value Market Share by Region (2023-2028)
Table 6. World Roflumilast Production by Region (2017-2022) & (Box)
Table 7. World Roflumilast Production by Region (2023-2028) & (Box)
Table 8. World Roflumilast Production Market Share by Region (2017-2022)
Table 9. World Roflumilast Production Market Share by Region (2023-2028)
Table 10. World Roflumilast Average Price by Region (2017-2022) & (US$/Box)
Table 11. World Roflumilast Average Price by Region (2023-2028) & (US$/Box)
Table 12. Roflumilast Major Market Trends
Table 13. World Roflumilast Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Box)
Table 14. World Roflumilast Consumption by Region (2017-2022) & (Box)
Table 15. World Roflumilast Consumption Forecast by Region (2023-2028) & (Box)
Table 16. World Roflumilast Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Roflumilast Producers in 2021
Table 18. World Roflumilast Production by Manufacturer (2017-2022) & (Box)
Table 19. Production Market Share of Key Roflumilast Producers in 2021
Table 20. World Roflumilast Average Price by Manufacturer (2017-2022) & (US$/Box)
Table 21. Global Roflumilast Company Evaluation Quadrant
Table 22. World Roflumilast Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Roflumilast Production Site of Key Manufacturer
Table 24. Roflumilast Market: Company Product Type Footprint
Table 25. Roflumilast Market: Company Product Application Footprint
Table 26. Roflumilast Competitive Factors
Table 27. Roflumilast New Entrant and Capacity Expansion Plans
Table 28. Roflumilast Mergers & Acquisitions Activity
Table 29. United States VS China Roflumilast Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Roflumilast Production Comparison, (2017 & 2021 & 2028) & (Box)
Table 31. United States VS China Roflumilast Consumption Comparison, (2017 & 2021 & 2028) & (Box)
Table 32. Major Manufacturer of Roflumilast in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 36. United States Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Roflumilast in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 41. China Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Roflumilast in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Roflumilast Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Roflumilast Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Roflumilast Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 46. Rest of World Roflumilast Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Roflumilast Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Table 48. World Roflumilast Production by Dosage Strength (2017-2022) & (Box)
Table 49. World Roflumilast Production by Dosage Strength (2023-2028) & (Box)
Table 50. World Roflumilast Production Value by Dosage Strength (2017-2022) & (USD Million)
Table 51. World Roflumilast Production Value by Dosage Strength (2023-2028) & (USD Million)
Table 52. World Roflumilast Average Price by Dosage Strength (2017-2022) & (US$/Box)
Table 53. World Roflumilast Average Price by Dosage Strength (2023-2028) & (US$/Box)
Table 54. World Roflumilast Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Roflumilast Production by Application (2017-2022) & (Box)
Table 56. World Roflumilast Production by Application (2023-2028) & (Box)
Table 57. World Roflumilast Production Value by Application (2017-2022) & (USD Million)
Table 58. World Roflumilast Production Value by Application (2023-2028) & (USD Million)
Table 59. World Roflumilast Average Price by Application (2017-2022) & (US$/Box)
Table 60. World Roflumilast Average Price by Application (2023-2028) & (US$/Box)
Table 61. Alkem Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Alkem Laboratories Major Business
Table 63. Alkem Laboratories Roflumilast Product and Services
Table 64. Alkem Laboratories Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Alkem Laboratories Recent Developments/Updates
Table 66. Alkem Laboratories Competitive Strengths & Weaknesses
Table 67. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 68. Astra Zeneca Major Business
Table 69. Astra Zeneca Roflumilast Product and Services
Table 70. Astra Zeneca Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Astra Zeneca Recent Developments/Updates
Table 72. Astra Zeneca Competitive Strengths & Weaknesses
Table 73. Beltapharm Spa Basic Information, Manufacturing Base and Competitors
Table 74. Beltapharm Spa Major Business
Table 75. Beltapharm Spa Roflumilast Product and Services
Table 76. Beltapharm Spa Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Beltapharm Spa Recent Developments/Updates
Table 78. Beltapharm Spa Competitive Strengths & Weaknesses
Table 79. Breckenridge Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Breckenridge Pharma Major Business
Table 81. Breckenridge Pharma Roflumilast Product and Services
Table 82. Breckenridge Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Breckenridge Pharma Recent Developments/Updates
Table 84. Breckenridge Pharma Competitive Strengths & Weaknesses
Table 85. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 86. Hetero Drugs Major Business
Table 87. Hetero Drugs Roflumilast Product and Services
Table 88. Hetero Drugs Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Hetero Drugs Recent Developments/Updates
Table 90. Hetero Drugs Competitive Strengths & Weaknesses
Table 91. KMS Health Center Basic Information, Manufacturing Base and Competitors
Table 92. KMS Health Center Major Business
Table 93. KMS Health Center Roflumilast Product and Services
Table 94. KMS Health Center Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. KMS Health Center Recent Developments/Updates
Table 96. KMS Health Center Competitive Strengths & Weaknesses
Table 97. Micro Labs Basic Information, Manufacturing Base and Competitors
Table 98. Micro Labs Major Business
Table 99. Micro Labs Roflumilast Product and Services
Table 100. Micro Labs Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Micro Labs Recent Developments/Updates
Table 102. Micro Labs Competitive Strengths & Weaknesses
Table 103. MS Pharma Basic Information, Manufacturing Base and Competitors
Table 104. MS Pharma Major Business
Table 105. MS Pharma Roflumilast Product and Services
Table 106. MS Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. MS Pharma Recent Developments/Updates
Table 108. MS Pharma Competitive Strengths & Weaknesses
Table 109. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 110. MSN Laboratories Major Business
Table 111. MSN Laboratories Roflumilast Product and Services
Table 112. MSN Laboratories Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. MSN Laboratories Recent Developments/Updates
Table 114. MSN Laboratories Competitive Strengths & Weaknesses
Table 115. Viatris Basic Information, Manufacturing Base and Competitors
Table 116. Viatris Major Business
Table 117. Viatris Roflumilast Product and Services
Table 118. Viatris Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Viatris Recent Developments/Updates
Table 120. Viatris Competitive Strengths & Weaknesses
Table 121. Orchid Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Orchid Pharma Major Business
Table 123. Orchid Pharma Roflumilast Product and Services
Table 124. Orchid Pharma Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Orchid Pharma Recent Developments/Updates
Table 126. Orchid Pharma Competitive Strengths & Weaknesses
Table 127. Orifarm Group Basic Information, Manufacturing Base and Competitors
Table 128. Orifarm Group Major Business
Table 129. Orifarm Group Roflumilast Product and Services
Table 130. Orifarm Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Orifarm Group Recent Developments/Updates
Table 132. Orifarm Group Competitive Strengths & Weaknesses
Table 133. Precise Group Basic Information, Manufacturing Base and Competitors
Table 134. Precise Group Major Business
Table 135. Precise Group Roflumilast Product and Services
Table 136. Precise Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Precise Group Recent Developments/Updates
Table 138. Precise Group Competitive Strengths & Weaknesses
Table 139. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Takeda Pharmaceutical Major Business
Table 141. Takeda Pharmaceutical Roflumilast Product and Services
Table 142. Takeda Pharmaceutical Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Takeda Pharmaceutical Recent Developments/Updates
Table 144. Torrent Group Basic Information, Manufacturing Base and Competitors
Table 145. Torrent Group Major Business
Table 146. Torrent Group Roflumilast Product and Services
Table 147. Torrent Group Roflumilast Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Roflumilast Raw Material
Table 149. Key Manufacturers of Roflumilast Raw Materials
Table 150. Roflumilast Typical Distributors
Table 151. Roflumilast Typical Customers
LIST OF FIGURES
Figure 1. Roflumilast Picture
Figure 2. World Roflumilast Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Roflumilast Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Roflumilast Production (2017-2028) & (Box)
Figure 5. World Roflumilast Average Price (2017-2028) & (US$/Box)
Figure 6. World Roflumilast Production Value Market Share by Region (2017-2028)
Figure 7. World Roflumilast Production Market Share by Region (2017-2028)
Figure 8. North America Roflumilast Production (2017-2028) & (Box)
Figure 9. Europe Roflumilast Production (2017-2028) & (Box)
Figure 10. China Roflumilast Production (2017-2028) & (Box)
Figure 11. Japan Roflumilast Production (2017-2028) & (Box)
Figure 12. Roflumilast Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Roflumilast Demand (2017-2028) & (Box)
Figure 15. World Roflumilast Consumption Market Share by Region (2017-2028)
Figure 16. United States Roflumilast Consumption (2017-2028) & (Box)
Figure 17. China Roflumilast Consumption (2017-2028) & (Box)
Figure 18. Europe Roflumilast Consumption (2017-2028) & (Box)
Figure 19. Japan Roflumilast Consumption (2017-2028) & (Box)
Figure 20. South Korea Roflumilast Consumption (2017-2028) & (Box)
Figure 21. ASEAN Roflumilast Consumption (2017-2028) & (Box)
Figure 22. India Roflumilast Consumption (2017-2028) & (Box)
Figure 23. Producer Shipments of Roflumilast by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Roflumilast Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Roflumilast Markets in 2021
Figure 26. United States VS China: Roflumilast Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Roflumilast Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Roflumilast Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Roflumilast in United States
Figure 30. Key Producers and Market Share of Roflumilast in China
Figure 31. Key Producers and Market Share of Roflumilast in Rest of World
Figure 32. World Roflumilast Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Figure 33. World Roflumilast Production Value Market Share by Dosage Strength in 2021
Figure 34. 250Mcg
Figure 35. 500Mcg
Figure 36. World Roflumilast Production Market Share by Dosage Strength (2017-2028)
Figure 37. World Roflumilast Production Value Market Share by Dosage Strength (2017-2028)
Figure 38. World Roflumilast Average Price by Dosage Strength (2017-2028) & (US$/Box)
Figure 39. World Roflumilast Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Roflumilast Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Roflumilast Production Market Share by Application (2017-2028)
Figure 45. World Roflumilast Production Value Market Share by Application (2017-2028)
Figure 46. World Roflumilast Average Price by Application (2017-2028) & (US$/Box)
Figure 47. Manufacturing Cost Structure Analysis of Roflumilast in 2021
Figure 48. Manufacturing Process Analysis of Roflumilast
Figure 49. Roflumilast Industrial Chain
Figure 50. Distribution Channel Breakdown for Roflumilast Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Roflumilast Picture
Figure 2. World Roflumilast Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Roflumilast Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Roflumilast Production (2017-2028) & (Box)
Figure 5. World Roflumilast Average Price (2017-2028) & (US$/Box)
Figure 6. World Roflumilast Production Value Market Share by Region (2017-2028)
Figure 7. World Roflumilast Production Market Share by Region (2017-2028)
Figure 8. North America Roflumilast Production (2017-2028) & (Box)
Figure 9. Europe Roflumilast Production (2017-2028) & (Box)
Figure 10. China Roflumilast Production (2017-2028) & (Box)
Figure 11. Japan Roflumilast Production (2017-2028) & (Box)
Figure 12. Roflumilast Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Roflumilast Demand (2017-2028) & (Box)
Figure 15. World Roflumilast Consumption Market Share by Region (2017-2028)
Figure 16. United States Roflumilast Consumption (2017-2028) & (Box)
Figure 17. China Roflumilast Consumption (2017-2028) & (Box)
Figure 18. Europe Roflumilast Consumption (2017-2028) & (Box)
Figure 19. Japan Roflumilast Consumption (2017-2028) & (Box)
Figure 20. South Korea Roflumilast Consumption (2017-2028) & (Box)
Figure 21. ASEAN Roflumilast Consumption (2017-2028) & (Box)
Figure 22. India Roflumilast Consumption (2017-2028) & (Box)
Figure 23. Producer Shipments of Roflumilast by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Roflumilast Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Roflumilast Markets in 2021
Figure 26. United States VS China: Roflumilast Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Roflumilast Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Roflumilast Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Roflumilast in United States
Figure 30. Key Producers and Market Share of Roflumilast in China
Figure 31. Key Producers and Market Share of Roflumilast in Rest of World
Figure 32. World Roflumilast Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Figure 33. World Roflumilast Production Value Market Share by Dosage Strength in 2021
Figure 34. 250Mcg
Figure 35. 500Mcg
Figure 36. World Roflumilast Production Market Share by Dosage Strength (2017-2028)
Figure 37. World Roflumilast Production Value Market Share by Dosage Strength (2017-2028)
Figure 38. World Roflumilast Average Price by Dosage Strength (2017-2028) & (US$/Box)
Figure 39. World Roflumilast Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Roflumilast Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Roflumilast Production Market Share by Application (2017-2028)
Figure 45. World Roflumilast Production Value Market Share by Application (2017-2028)
Figure 46. World Roflumilast Average Price by Application (2017-2028) & (US$/Box)
Figure 47. Manufacturing Cost Structure Analysis of Roflumilast in 2021
Figure 48. Manufacturing Process Analysis of Roflumilast
Figure 49. Roflumilast Industrial Chain
Figure 50. Distribution Channel Breakdown for Roflumilast Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
